Details About Generic Salt ::  Docetaxel 

Main Medicine Class:: Anti Neoplastic Agents   Sub Medicine Class ::  Anti Neoplastic Agents

18A. ANTI-NEOPLASTIC AGENTS in 18. ANTI-NEOPLASTIC AGENTS
DOCETAXEL
SEMISYNTHETIC TAXANE | ANTI-NEOPLASTIC
PK: D: 80-90 L/m2 (Vd), Vdss: 113 L (mean steady state) M: Hepatic E: Feces (~75%, <8% as unchanged drug), urine (<5%)

Indications & Dose: GASTRIC ADENOCARCINOMA Combination therapy IV Adult 75mg/m2 over 1h q3wk with cispaltin & fluorouracil | HEAD/NECK CANCER Combination therapy IV Adult 75mg/m2 over 1h q3wk with cispaltin & fluorouracil for 3 or 4 cycles followed by radiation therapy | LOCALLY-ADVANCED/METASTATIC BREAST CANCER Mono therapy IV Adult 60-100mg/m2 over 1h q3wk | NON-SMALL-CELL LUNG CANCER Combination therapy IV Adult 75mg/m2 over 1h q3wk with cispaltin | Mono therapy IV Adult 75mg/m2 over 1h q3wk | OPERABLE NODE-POSITIVE BREAST CANCER Combination therapy/Adjuvant therapy IV Adult 75mg/m2 over 1h (doxorubicin 50mg/m2 & cyclophosphamide 500mg/m2 1h after docetaxel) repeated q3wk for six courses | PROSTATE CANCER IV Adult 75mg/m2 over 1h q3wk with prednisone

Contra: Hypersensitivity, severe hypersensitivity to other medications containing polysorbate 80, neutrophil count <1500/mm3, acute infect, severely impaired hepatic function

Precautions: Mild-to-moderate hepatic impairment, debilitated patients, depressed bone marrow from radiotherapy/therapy with other anti-neoplastics

ADR: Serious: Fluid retention, neurosensory events, neuromotor events, cutaneous events, blood disorders, transaminases increased, pulmonary events, infect, hypersensitivity, left ventricular ejection fraction decreased, hypotension, bilirubin/alkaline phosphatase increased, epiphora associated with canalicular stenosis, Others: arthralgia, weakness, myalgia, nail disorder, diarrhea, nausea, vomiting, alopecia, fever

DDI: Serious HIV protease inhibitors causes hematological toxicities, Docetaxel causes neurotoxicity, Ketoconazole decreases the clearance of drug, Sorafenib increase drug level, Ciclosporin increases drug level, Rifampicin/Barbiturates reduce drug level

Monitor: CBC with differential, LFTs, renal function, monitor for hypersensitivity reactions, neurosensory symptoms, gastrointestinal toxicity, cutaneous reactions, fluid retention, epiphora, canalicular stenosis

We would like to keep you updated with special notifications.